Network analysis of associations between serum interferon-α activity, autoantibodies, and clinical features in systemic lupus erythematosus - Test2 - elhamkhani - TriplyDB

Network analysis of associations between serum interferon-α activity, autoantibodies, and clinical features in systemic lupus erythematosus

Network analysis of associations between serum interferon-α activity, autoantibodies, and clinical features in systemic lupus erythematosus

http://www.wikidata.org/entity/Q28301151

about

Dysregulation of antiviral helicase pathways in systemic lupus erythematosus Nucleic Acid sensors and type I interferon production in systemic lupus erythematosus Type I interferon blockade in systemic lupus erythematosus: where do we stand?Pathogenesis and prevention of rheumatic disease: focus on preclinical RA and SLE Advances in lupus genetics Familial aggregation of autoimmune disease in juvenile dermatomyositis IRF5 haplotypes demonstrate diverse serological associations which predict serum interferon alpha activity and explain the majority of the genetic association with systemic lupus erythematosus Brief Report: IRF5 systemic lupus erythematosus risk haplotype is associated with asymptomatic serologic autoimmunity and progression to clinical autoimmunity in mothers of children with neonatal lupus Admixture mapping in lupus identifies multiple functional variants within IFIH1 associated with apoptosis, inflammation, and autoantibody production Immunogenicity and Lupus-Like Autoantibody Production Can Be Linked to Each Other along With Type I Interferon Production in Patients with Rheumatoid Arthritis Treated With Infliximab: A Retrospective Study of a Single Center Cohort Abnormalities of frontal-parietal resting-state functional connectivity are related to disease activity in patients with systemic lupus erythematosus.Osteopontin alleles are associated with clinical characteristics in systemic lupus erythematosus.An essential role of caspase 1 in the induction of murine lupus and its associated vascular damage Two major autoantibody clusters in systemic lupus erythematosus Activation of type I interferon pathway in systemic lupus erythematosus: association with distinct clinical phenotypes.Type I interferons are associated with subclinical markers of cardiovascular disease in a cohort of systemic lupus erythematosus patients.Association of functional polymorphisms in interferon regulatory factor 2 (IRF2) with susceptibility to systemic lupus erythematosus: a case-control association study.Sex Differences in monocytes and TLR4 associated immune responses; implications for systemic lupus erythematosus (SLE)Plasma levels of galectin-3-binding protein reflect type I interferon activity and are increased in patients with systemic lupus erythematosus.Sex differences in monocyte activation in systemic lupus erythematosus (SLE).Interferon regulatory factors in human lupus pathogenesis Genetic analysis of the pathogenic molecular sub-phenotype interferon-alpha identifies multiple novel loci involved in systemic lupus erythematosus.Interferon regulatory factors: critical mediators of human lupus.Vitamin D deficiency is associated with an increased autoimmune response in healthy individuals and in patients with systemic lupus erythematosus Inflammasome activation of IL-18 results in endothelial progenitor cell dysfunction in systemic lupus erythematosus.B lymphocyte stimulator levels in systemic lupus erythematosus: higher circulating levels in African American patients and increased production after influenza vaccination in patients with low baseline levels.Interferon alpha as a primary pathogenic factor in human lupus Widely divergent transcriptional patterns between SLE patients of different ancestral backgrounds in sorted immune cell populations Genome-Wide Assessment of Differential DNA Methylation Associated with Autoantibody Production in Systemic Lupus Erythematosus.Clinical and serological manifestations associated with interferon-α levels in childhood-onset systemic lupus erythematosus.The autoimmune disease risk allele of UBE2L3 in African American patients with systemic lupus erythematosus: a recessive effect upon subphenotypes.Autoimmune disease risk variant of IFIH1 is associated with increased sensitivity to IFN-α and serologic autoimmunity in lupus patients.Role of cytokines in systemic lupus erythematosus: recent progress from GWAS and sequencing.Myeloid dendritic cells from B6.NZM Sle1/Sle2/Sle3 lupus-prone mice express an IFN signature that precedes disease onset Genetic ancestry, serum interferon-α activity, and autoantibodies in systemic lupus erythematosus Large-scale analysis of tumor necrosis factor α levels in systemic lupus erythematosus Gene-expression-guided selection of candidate loci and molecular phenotype analyses enhance genetic discovery in systemic lupus erythematosus.Enhanced rho-associated protein kinase activation in patients with systemic lupus erythematosus.Serum progranulin levels are elevated in patients with systemic lupus erythematosus, reflecting disease activity.Activation of the Interferon Pathway is Dependent Upon Autoantibodies in African-American SLE Patients, but Not in European-American SLE Patients.

P2860

Q21129494-B521FA96-48A0-415B-8385-2D5A97B3E0B4 Q21131202-D011891C-13D9-4CDA-BF7F-73F3041496A9 Q26865441-339B31CD-AAA8-43D6-9383-806DC37FCD89 Q27003201-A545358B-BB69-4806-B135-B4BF2B3E57F3 Q28088718-F4B4EA92-CFF1-4911-B667-1DE49E70E156 Q28235854-B6DEEF61-8661-415C-9052-0D44509EB1B4 Q28253129-75A2BAF9-C09B-495A-A6DD-B6B2995DE504 Q28268287-237F401D-CB27-4843-A5AD-37C3BFFFC67E Q28486228-34F2B03A-5B61-45EC-A05E-A2323717BD3F Q28554222-59D87BE5-DE11-4BCC-8DBB-AE28A4DBBCC9 Q33163321-CFE26D2F-A31D-4F47-8B89-0DF4604DF2BA Q33398517-6A35EE66-AEF1-4298-9AFE-E0B6577C6E6B Q34055844-C20730E1-C26A-48E4-AAB7-AE0A46E1F1BF Q34171558-C0376C09-51B0-4A84-AA92-6D81A07B523B Q34240254-BAF63CDC-D449-43CA-B47E-442F8906462E Q34273836-BF6475ED-ECCA-40DB-B258-72BD87190993 Q34294364-855083C0-2B4D-4E90-BB08-E35FF6867A6F Q34323715-368BE1D6-33C0-4F39-B40E-C24FAECBD0DC Q34583337-6E2873A8-0782-43A3-87E7-D61015432BBA Q34653871-BAB76245-04D9-4987-9588-4388B74C6060 Q34988497-6FEC66FB-A9B5-42BE-AFF2-7D54CDCC432E Q35008001-C24D28A8-6F3E-49E9-8FA5-301B6D741837 Q35014051-AE41F875-46FB-4BC3-AE4E-B43FD3257DC3 Q35146576-3C312185-3678-4E08-AD60-F721D116C0B0 Q35566819-B293723C-0A91-4D90-A220-F2380AC1B001 Q35602526-85B67FFF-883C-4EA4-ADC0-99371212F47B Q35603587-F7F8407F-5443-46D4-A27F-C2E82B88F521 Q35688808-EC51CF09-C6EB-4DD6-A003-EA7FC05035D6 Q35698898-F417F95C-4F3F-4D00-8D10-ABBB3D9C5E8D Q35743904-06D7474F-CD87-45E9-A5D4-2BBA4650EF2A Q35832505-3FC99516-E8E6-4A9B-A48E-4136D207B0DD Q35832527-12E1FBBE-3EDB-4C91-A841-D1060EDFA123 Q35986928-0844AD31-340C-47BA-B5E4-F3F3ACBC93B8 Q36054583-1AA8BB6B-3BC4-4BCC-A8C5-40DD4E9E3BE7 Q36054951-1B15586A-141E-4495-A7EF-9C21CB9215DA Q36095071-3E7B365B-45BE-4777-9322-6A96939611B7 Q36228760-E9262784-9F8E-49B2-AC4F-81FA55989E37 Q36901827-ECB74207-EDEF-4C32-938C-A6ED35C605D7 Q36907736-C4A35FCA-B0CC-4414-A078-432B8E6AC007 Q37208233-49C2FD12-375F-45AA-BC1F-3CC3374786D8

P2860

Network analysis of associations between serum interferon-α activity, autoantibodies, and clinical features in systemic lupus erythematosus

http://www.wikidata.org/entity/Q28301151

description

2011 nî lūn-bûn

@nan

2011 թուականի Ապրիլին հրատարակուած գիտական յօդուած

@hyw

2011 թվականի ապրիլին հրատարակված գիտական հոդված

@hy

2011年の論文

@ja

2011年論文

@yue

2011年論文

@zh-hant

2011年論文

@zh-hk

2011年論文

@zh-mo

2011年論文

@zh-tw

2011年论文

@wuu

name

Network analysis of associatio ...... n systemic lupus erythematosus

@ast

Network analysis of associatio ...... n systemic lupus erythematosus

@en

Network analysis of associatio ...... n systemic lupus erythematosus

@nl

type

label

Network analysis of associatio ...... n systemic lupus erythematosus

@ast

Network analysis of associatio ...... n systemic lupus erythematosus

@en

Network analysis of associatio ...... n systemic lupus erythematosus

@nl

prefLabel

Network analysis of associatio ...... n systemic lupus erythematosus

@ast

Network analysis of associatio ...... n systemic lupus erythematosus

@en

Network analysis of associatio ...... n systemic lupus erythematosus

@nl

P1433

Q28301151-8C3DF865-FE74-4D1F-88CB-D5D37EC213B1

P1476

Q28301151-1E0816C3-0205-40B6-B38A-A1758691A6C9

P2093

Q28301151-251DFA01-7A13-4A3B-AF8C-CB57D83B2EE3

Q28301151-391CB297-BDD9-4466-8BE0-77B1629D8420

Q28301151-61069829-BE7C-44F5-9800-46F680DD5A75

Q28301151-6770050A-6526-4B15-8655-7FD5230AC299

Q28301151-7066806C-1D93-413A-A401-E433E091B543

Q28301151-8C13983D-AAEC-4075-B69F-0C588F47CBBE

Q28301151-B7786A6D-1E68-4AFA-8B1B-2F28C3B3EAFE

P2860

Q28301151-002BA6EC-662B-4B5D-9E9C-02178A0CB891

Q28301151-0C6E7A2E-03AB-4002-8059-F381B4855731

Q28301151-110EBE74-D25C-4327-B206-6B03A68E58BA

Q28301151-1D6A088C-F11B-42C8-B339-EC4089406548

Q28301151-1F47E575-5CA8-4091-861A-B512055DA4F1

Q28301151-1FBF7798-8A74-425F-8EE5-E5ADC179777C

Q28301151-254BBB44-6727-4C11-8E2C-08B62D2639E4

Q28301151-2DAD590D-0740-4045-8D0F-C0907227E8BF

Q28301151-3AFC1657-BE90-4D5C-AB63-19C98ED1A1D6

Q28301151-3B9C3D22-47D1-4DB8-8C80-13724509507A

P304

Q28301151-5F443DAC-8312-4A62-874A-732EDAEEA16B

P31

Q28301151-A0ABA4C4-6C74-436C-B934-997B170F9689

P3181

Q28301151-6B312FD0-8031-46E1-BF3C-F4B8E4A2ED94

P356

Q28301151-13E983F0-8F2A-46D0-A2AC-04BAA3FBB92D

P407

Q28301151-4EF4AFEE-3BCB-4CBA-A34B-9B89792E0060

P433

Q28301151-8380C5EF-9CF2-45AA-B6F5-12F03778E0EE

P478

Q28301151-DDAF7415-6F74-431D-8ADB-2FBC446C0EBA

P50

Q28301151-1ACD600E-2A2B-43D1-96C1-588560992B74

Q28301151-5DD3E019-21CC-4E37-97D4-15697EC66CB9

Q28301151-DA23256C-3011-4D9A-B152-5EFB7CDE5F8C

Q28301151-DEDDB87A-AD11-4C7F-9A51-7296F877CAC8

P577

Q28301151-BCF70796-1D4A-45B6-B037-DBA7C5F9B354

P5875

Q28301151-A1A7B1DD-3223-4CA0-98BA-6CFE270B24B5

P698

Q28301151-2E29094D-4613-4964-B9FB-07E7826F1DE1

P921

Q28301151-9DA143CF-2CF2-483A-AD50-4820F042F599

P932

Q28301151-08E1D30D-C81C-409A-AEA8-27EED0EAD9A3

P3181

P356

P1433

Arthritis & Rheumatology

P1476

Network analysis of associatio ...... n systemic lupus erythematosus

@en

P2093

Beverly S Franek

http://www.w3.org/2001/XMLSchema#string

Corinna E Weckerle

http://www.w3.org/2001/XMLSchema#string

Marissa Kumabe

http://www.w3.org/2001/XMLSchema#string

Meenakshi Jolly

http://www.w3.org/2001/XMLSchema#string

Rachel A Mikolaitis

http://www.w3.org/2001/XMLSchema#string

Stephanie L Green

http://www.w3.org/2001/XMLSchema#string

Tammy O Utset

http://www.w3.org/2001/XMLSchema#string

P2860

The role of genetic variation near interferon-kappa in systemic lupus erythematosus

Interferon-inducible gene expression signature in peripheral blood cells of patients with severe lupus

Interferon alpha-induced lupus: proof of principle

High serum IFN-alpha activity is a heritable risk factor for systemic lupus erythematosus

The 1982 revised criteria for the classification of systemic lupus erythematosus

Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus

Longitudinal expression of type I interferon responsive genes in systemic lupus erythematosus.

Differences by race, sex and age in the clinical and immunologic features of recently diagnosed systemic lupus erythematosus patients in the southeastern United States.

Features associated with, and the impact of, hemolytic anemia in patients with systemic lupus erythematosus: LX, results from a multiethnic cohort.

Clinical features and race-specific incidence/prevalence rates of systemic lupus erythematosus in a geographically complete cohort of patients.

P304

1044-53

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

3469405

http://www.w3.org/2001/XMLSchema#string

P356

10.1002/ART.30187

http://www.w3.org/2001/XMLSchema#string

P407

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

63

http://www.w3.org/2001/XMLSchema#string

P50

Timothy B. Niewold

Jennifer A Kelly

Judith A. James

P577

2011-04-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

49687023

http://www.w3.org/2001/XMLSchema#string

P698

21162028

http://www.w3.org/2001/XMLSchema#string

P921

P932

3068224

http://www.w3.org/2001/XMLSchema#string